EMA Backs Approval For Eight New Drugs But Rejects Lagevrio For COVID-19

 
• By Neena Brizmohun

Janssen’s Akeega is among the latest drugs that the European Medicines Agency says should be approved for use in the EU. Meanwhile, MSD/Ridgeback Biotherapeutics plan to appeal the agency’s rejection of their COVID-19 treatment.

The EMA recommended approval for eight drugs but rejected another one • Source: Shutterstock

More from Approvals

More from Product Reviews